Search the MBS

Related Items: 695 10987 10997 19000

• Previous - Note AN.14.2
• Next - Note AN.15.1

Related Items: 12306 12312 12315 12320 12321 12322

• Previous - Note DN.1.17
• Next - Note DN.1.19

• Previous - Note GN.11.29
• Next - Note GN.12.31

Menopause and Perimenopause Health Assessment

Professional attendance on a patient for the assessment and management of menopause or perimenopause by a general practitioner lasting at least 20 minutes and including, but not limited to:

a) collecting relevant information, including taking a patient history to determine pre-, peri- or post-menopausal status, patient wellbeing and contraindications for management; and

b) undertaking a basic physical examination, including recording blood pressure, and review of height and weight; and

c) initiating investigations and referrals as clinically indicated, with consideration given to the need for cervical screening, mammography and bone densitometry; and

d) discussing management options including non-pharmacological and pharmacological strategies including risks and benefits;

e) implementing a management plan which includes patient centred symptoms management; and

f) providing the patient with preventative health care advice and information as clinically indicated, including advice on physical activity, smoking cessation, alcohol consumption, nutritional intake and weight management.

Fee: $104.55 Benefit: 100% = $104.55

(See para AN.14.3 of explanatory notes to this Category)

Extended Medicare Safety Net Cap: $313.65

• Previous - Item 600
• Next - Item 699

Bone densitometry, using dual energy X‑ray absorptiometry, involving the measurement of 2 or more sites (including interpretation and reporting), for:

(a) confirmation of a presumptive diagnosis of low bone mineral density made on the basis of one or more fractures occurring after minimal trauma; or

(b) monitoring of low bone mineral density proven by bone densitometry at least 12 months previously;

other than a service associated with a service to which item 12312, 12315 or 12321 applies

For any particular patient, once only in a 24 month period

Fee: $122.55 Benefit: 75% = $91.95 85% = $104.20

(See para DN.1.18 of explanatory notes to this Category)

• Previous - Item 12272
• Next - Item 12312

Bone densitometry, using dual energy X‑ray absorptiometry, involving the measurement of 2 or more sites (including interpretation and reporting) for diagnosis and monitoring of bone loss associated with one or more of the following:

(a) prolonged glucocorticoid therapy;

(b) any condition associated with excess glucocorticoid secretion;

(c) male hypogonadism;

(d) female hypogonadism lasting more than 6 months before the age of 45;

other than a service associated with a service to which item 12306, 12315 or 12321 applies

For any particular patient, once only in a 12 month period 

Fee: $122.55 Benefit: 75% = $91.95 85% = $104.20

(See para DN.1.18 of explanatory notes to this Category)

• Previous - Item 12306
• Next - Item 12315

Bone densitometry, using dual energy X‑ray absorptiometry, involving the measurement of 2 or more sites (including interpretation and reporting) for diagnosis and monitoring of bone loss associated with one or more of the following conditions:

(a) primary hyperparathyroidism;

(b) chronic liver disease;

(c) chronic renal disease;

(d) any proven malabsorptive disorder;

(e) rheumatoid arthritis;

(f) any condition associated with thyroxine excess;

other than a service associated with a service to which item 12306, 12312 or 12321 applies

For any particular patient, once only in a 24 month period

Fee: $122.55 Benefit: 75% = $91.95 85% = $104.20

(See para DN.1.18 of explanatory notes to this Category)

• Previous - Item 12312
• Next - Item 12320

Bone densitometry, using dual energy X‑ray absorptiometry or quantitative computed tomography, involving the measurement of 2 or more sites (including interpretation and reporting) for measurement of bone mineral density, if:

(a) the patient is 70 years of age or over, and

(b) either:

     (i)  the patient has not previously had bone densitometry; or

     (ii) the t-score for the patient's bone mineral density is -1.5 or more;

other than a service associated with a service to which item 12306, 12312, 12315, 12321 or 12322 applies

For any particular patient, once only in a 5 year period

Fee: $122.55 Benefit: 75% = $91.95 85% = $104.20

(See para DN.1.18 of explanatory notes to this Category)

• Previous - Item 12315
• Next - Item 12321

Bone densitometry, using dual energy X‑ray absorptiometry, involving the measurement of 2 or more sites at least 12 months after a significant change in therapy (including interpretation and reporting), for:

(a) established low bone mineral density; or

(b) confirming a presumptive diagnosis of low bone mineral density made on the basis of one or more fractures occurring after minimal trauma;

other than a service associated with a service to which item 12306, 12312 or 12315 applies

For any particular patient, once only in a 12 month period

Fee: $122.55 Benefit: 75% = $91.95 85% = $104.20

(See para DN.1.18 of explanatory notes to this Category)

• Previous - Item 12320
• Next - Item 12322

Bone densitometry, using dual energy X‑ray absorptiometry or quantitative computed tomography, involving the measurement of 2 or more sites (including interpretation and reporting) for measurement of bone mineral density, if:

(a) the patient is 70 years of age or over; and

(b) the t‑score for the patient's bone mineral density is less than ‑1.5 but more than ‑2.5;

other than a service associated with a service to which item 12306, 12312, 12315, 12320 or 12321 applies

For any particular patient, once only in a 2 year period 

Fee: $122.55 Benefit: 75% = $91.95 85% = $104.20

(See para DN.1.18 of explanatory notes to this Category)

• Previous - Item 12321
• Next - Item 12325